2003N-0059 - Pharmaceutical Current Good Manufacturing Practices for the 21st Century: A Risk-Based Approach
  


  

  
FDA Comment Number : 
  

  
EC35
  



  

  

  



  

  
Submitter : 
  

  
Dr. Henry Chuang
  

  
Date & Time: 
  

  
07/31/2003 05:07:05
  



  

  
Organization : 
  

  
Calgary Health Region
  



  

  
Category : 
  

  
Health Professional
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 Dear Sir/Madam:

Under the 21 CFR 206.10 specifing requirement of code imprint on tablets and pills, is there a reason why FDA does not require imprinting of the drug name so as not to cause confusion among patients and medical staff especially in cases of overdose, and caregivers having to second guess the drug by its color and shape?  Thanks.  Henry T. Chuang, M.D.